330 related articles for article (PubMed ID: 23391109)
1. The evolving landscape of neuroendocrine tumors.
Bergsland EK
Semin Oncol; 2013 Feb; 40(1):4-22. PubMed ID: 23391109
[TBL] [Abstract][Full Text] [Related]
2. Management of gastroentero-pancreatic neuroendocrine tumors (GEP-NETs).
Desai KK; Khan MS; Toumpanakis C; Caplin ME
Minerva Gastroenterol Dietol; 2009 Dec; 55(4):425-43. PubMed ID: 19942827
[TBL] [Abstract][Full Text] [Related]
3. An update on gastroenteropancreatic neuroendocrine tumors.
Cives M; Strosberg J
Oncology (Williston Park); 2014 Sep; 28(9):749-56, 758. PubMed ID: 25224471
[TBL] [Abstract][Full Text] [Related]
4. Systemic therapeutic options for carcinoid.
Pavel M; Kidd M; Modlin I
Semin Oncol; 2013 Feb; 40(1):84-99. PubMed ID: 23391116
[TBL] [Abstract][Full Text] [Related]
5. Advances in the systemic treatment of neuroendocrine tumors in the era of molecular therapy.
Leung R; Lang B; Wong H; Chiu J; Yat WK; Shek T; Cho WY; Yau LC; Yau T
Anticancer Agents Med Chem; 2013 Mar; 13(3):382-8. PubMed ID: 23092266
[TBL] [Abstract][Full Text] [Related]
6. Role of somatostatins in gastroenteropancreatic neuroendocrine tumor development and therapy.
Oberg KE; Reubi JC; Kwekkeboom DJ; Krenning EP
Gastroenterology; 2010 Sep; 139(3):742-53, 753.e1. PubMed ID: 20637207
[TBL] [Abstract][Full Text] [Related]
7. Novel anticancer agents in clinical trials for well-differentiated neuroendocrine tumors.
Faivre S; Sablin MP; Dreyer C; Raymond E
Endocrinol Metab Clin North Am; 2010 Dec; 39(4):811-26. PubMed ID: 21095547
[TBL] [Abstract][Full Text] [Related]
8. Neuroendocrine tumors of the pancreas.
Milan SA; Yeo CJ
Curr Opin Oncol; 2012 Jan; 24(1):46-55. PubMed ID: 22080942
[TBL] [Abstract][Full Text] [Related]
9. [Neuroendocrine tumors of the gastrointestinal tract].
Arnold C
Praxis (Bern 1994); 2007 Jan; 96(1-2):19-28. PubMed ID: 17256557
[TBL] [Abstract][Full Text] [Related]
10. Everolimus in the treatment of renal cell carcinoma and neuroendocrine tumors.
Chan HY; Grossman AB; Bukowski RM
Adv Ther; 2010 Aug; 27(8):495-511. PubMed ID: 20623346
[TBL] [Abstract][Full Text] [Related]
11. Advances in the Diagnosis and Management of Well-Differentiated and Intermediate-Differentiated Neuroendocrine Tumors of the Lung.
Wolin EM
Chest; 2017 May; 151(5):1141-1146. PubMed ID: 27373769
[TBL] [Abstract][Full Text] [Related]
12. [New therapeutic strategies in gastroenteropancreatic neuroendocrine tumours].
Colao A; Pulcrano M; Dorato M; Müller F; Rossi FW; De Martino MC; Biondi B; Lombardi G
Minerva Endocrinol; 2001 Dec; 26(4):231-8. PubMed ID: 11782708
[TBL] [Abstract][Full Text] [Related]
13. Advances in chemotherapy and biotherapy of endocrine tumors.
Oberg K
Curr Opin Oncol; 1998 Jan; 10(1):58-65. PubMed ID: 9466486
[TBL] [Abstract][Full Text] [Related]
14. Pulmonary Neuroendocrine Tumors: Adjuvant and Systemic Treatments.
Uprety D; Halfdanarson TR; Molina JR; Leventakos K
Curr Treat Options Oncol; 2020 Aug; 21(11):86. PubMed ID: 32862320
[TBL] [Abstract][Full Text] [Related]
15. [Efficacy of somatostatin analogs in the treatment of neuroendocrine tumours and paraneoplastic syndromes].
Sperlongano P; De Falco M; Pisaniello D; Parmeggiani D; Parmeggiani U
Minerva Endocrinol; 2001 Dec; 26(4):293-5. PubMed ID: 11782719
[TBL] [Abstract][Full Text] [Related]
16. Pulmonary neuroendocrine/carcinoid tumors: a review article.
Bertino EM; Confer PD; Colonna JE; Ross P; Otterson GA
Cancer; 2009 Oct; 115(19):4434-41. PubMed ID: 19562772
[TBL] [Abstract][Full Text] [Related]
17. New and Emerging Treatment Options for Gastroenteropancreatic Neuroendocrine Tumors.
Phan AT; Kunz PL; Reidy-Lagunes DL
Clin Adv Hematol Oncol; 2015 May; 13(5 Suppl 5):1-18; quiz 1 p following 18. PubMed ID: 26430956
[TBL] [Abstract][Full Text] [Related]
18. Advances in the systemic treatment of pancreatic neuroendocrine tumors.
Yalcin S
Cancer Treat Rev; 2011 Apr; 37(2):127-32. PubMed ID: 20705397
[TBL] [Abstract][Full Text] [Related]
19. Medical management of pancreatic neuroendocrine tumors.
Delaunoit T; Neczyporenko F; Rubin J; Erlichman C; Hobday TJ
Am J Gastroenterol; 2008 Feb; 103(2):475-83; quiz 484. PubMed ID: 18028508
[TBL] [Abstract][Full Text] [Related]
20. Neuroendocrine tumors--somatostatin receptor expression and somatostatin analog treatment.
Janson ET; Oberg K
Cancer Chemother Biol Response Modif; 2003; 21():535-46. PubMed ID: 15338762
[No Abstract] [Full Text] [Related]
[Next] [New Search]